Roivant Sciences Ltd
F:87S
Roivant Sciences Ltd
F:87S
Price:
24.04
EUR
1.31%
Market Closed
Market Cap:
€17.8B
Relative Value
The Relative Value of one
87S
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 24.04 EUR,
Roivant Sciences Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
87S Relative Value
HIDDEN
Multiples Across Competitors
87S Competitors Multiples
Roivant Sciences Ltd Competitors
Roivant Sciences Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Roivant Sciences Ltd
F:87S
|
17.1B EUR | 1 509.6 | -24.8 | -12.8 | -12.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
412.8B USD | 6.7 | 98.6 | 16.1 | 22.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.6B USD | 6.2 | 21.5 | 13.4 | 16.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.4B USD | 10 | 30.5 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD | 5.6 | 18 | 13.4 | 15.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70B AUD | 3.2 | 35.5 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.4B EUR | 11.2 | 36.1 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
